ARV effects on HIV epidemiology and behaviors in Rakai, Uganda

抗逆转录病毒药物对乌干达拉凯艾滋病毒流行病学和行为的影响

基本信息

  • 批准号:
    7661429
  • 负责人:
  • 金额:
    $ 182.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-15 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The provision of HIV antiretroviral (ARV) therapy in Africa will have beneficial health and social effects, but will present many challenges. Since the drugs are now being initiated in Uganda, we have a narrow window of opportunity to assess the population-level impact of ARVs on HIV transmission and epidemiology, on behaviors in both HIV+ and HIV uninfected persons, and on sociodemographic indicators. Information is also needed on the emergence and transmission of drug resistance mutations, the effects of prior maternal nevirapine use on subsequent ARV effectiveness, and on barriers to ARV acceptance and adherence. The Rakai Health Sciences Program has received PEPFAR funds to initiate an ARV program in rural Rakai District, Uganda. Since 1994, we have conducted the Rakai Community Cohort Study (RCCS) and have longitudinal population-based information on HIV epidemiology, and on community risk behaviors, health and sociodemographic characteristics. These data provide a baseline for the assessment of ARV effects. Rakai has a mature, generalized epidemic, with a prevalence of 15% and an incidence of approximately 1.4/100 py. Under the proposed R01 (complementary to PEPFAR), we plan to conduct integrated quantitative and qualitative research in RCCS communities (n= 12,000 adults and approximately 600 children) and in non-RCCS comparison communities (n = 1,000 adults). We propose to examine epidemiological effects of ARVs (HIV incidence and prevalence; emergence and transmission of drug-resistant HIV, treatment acceptance and effectiveness, mother-to-child HIV transmission by subtype [A, D, AD recombinant]; as well as behavioral, social and demographic effects (behavioral disinhibition, use of HIV counseling and testing, use of other prevention services, contraceptive use, mortality, fertility, marital stability and orphanhood). We will also examine knowledge and attitudes towards ARVs, and the effects of stigma on ARV use. The study will provide unique data to guide HIV care in Africa and for projecting the course of the epidemic in the ARV era.
描述(由申请人提供):在非洲提供艾滋病毒抗逆转录病毒治疗将产生有益的健康和社会影响,但也会带来许多挑战。由于目前正在乌干达开始使用这些药物,我们有一个很小的机会来评估抗逆转录病毒药物对艾滋病毒传播和流行病学、对艾滋病毒阳性和未感染艾滋病毒者的行为以及对社会人口指标的人口影响。还需要关于耐药突变的出现和传播、母体先前使用奈韦拉平对随后抗逆转录病毒药物有效性的影响以及接受和坚持抗逆转录病毒药物的障碍等方面的信息。拉凯健康科学项目获得了总统防治艾滋病紧急救援计划的资金,在乌干达拉凯农村地区启动了一项抗逆转录病毒药物项目。自1994年以来,我们进行了Rakai社区队列研究(RCCS),并获得了关于艾滋病毒流行病学、社区危险行为、健康和社会人口特征的纵向人口信息。这些数据为评估抗逆转录病毒药物的影响提供了基线。Rakai是一种成熟的、广泛的流行病,患病率为15%,发病率约为1.4/100例。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Indices to measure risk of HIV acquisition in Rakai, Uganda.
  • DOI:
    10.1371/journal.pone.0092015
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Kagaayi J;Gray RH;Whalen C;Fu P;Neuhauser D;McGrath JW;Sewankambo NK;Serwadda D;Kigozi G;Nalugoda F;Reynolds SJ;Wawer MJ;Singer ME
  • 通讯作者:
    Singer ME
HIV Prevention Efforts and Incidence of HIV in Uganda.
  • DOI:
    10.1056/nejmoa1702150
  • 发表时间:
    2017-11-30
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Grabowski MK;Serwadda DM;Gray RH;Nakigozi G;Kigozi G;Kagaayi J;Ssekubugu R;Nalugoda F;Lessler J;Lutalo T;Galiwango RM;Makumbi F;Kong X;Kabatesi D;Alamo ST;Wiersma S;Sewankambo NK;Tobian AAR;Laeyendecker O;Quinn TC;Reynolds SJ;Wawer MJ;Chang LW;Rakai Health Sciences Program
  • 通讯作者:
    Rakai Health Sciences Program
Sexual coercion among adolescent women in Rakai, Uganda: does family structure matter?
乌干达拉凯青少年女性的性胁迫:家庭结构重要吗?
  • DOI:
    10.1177/0886260512468246
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Pilgrim,NanlestaA;Ahmed,Saifuddin;Gray,RonaldH;Sekasanvu,Joseph;Lutalo,Tom;Nalugoda,FredK;Serwadda,David;Wawer,MariaJ
  • 通讯作者:
    Wawer,MariaJ
Heterogeneity of the HIV epidemic in agrarian, trading, and fishing communities in Rakai, Uganda: an observational epidemiological study.
  • DOI:
    10.1016/s2352-3018(16)30034-0
  • 发表时间:
    2016-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chang LW;Grabowski MK;Ssekubugu R;Nalugoda F;Kigozi G;Nantume B;Lessler J;Moore SM;Quinn TC;Reynolds SJ;Gray RH;Serwadda D;Wawer MJ
  • 通讯作者:
    Wawer MJ
Sexual risk behaviors following circumcision among HIV-positive men in Rakai, Uganda.
  • DOI:
    10.1080/09540121.2018.1437253
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Kankaka EN;Ssekasanvu J;Prodger J;Nabukalu D;Nakawooya H;Ndyanabo A;Kigozi G;Gray R
  • 通讯作者:
    Gray R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria J Wawer其他文献

Maria J Wawer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria J Wawer', 18)}}的其他基金

Evaluating Demand Generation (Stylish Man) for HIV/Family Planning Services Rakai
评估艾滋病毒/计划生育服务的需求生成(时尚男士) Rakai
  • 批准号:
    9112869
  • 财政年份:
    2016
  • 资助金额:
    $ 182.22万
  • 项目类别:
Evaluating Demand Generation (Stylish Man) for HIV/Family Planning Services Rakai
评估艾滋病毒/计划生育服务的需求生成(时尚男士) Rakai
  • 批准号:
    8900943
  • 财政年份:
    2014
  • 资助金额:
    $ 182.22万
  • 项目类别:
Evaluating Demand Generation (Stylish Man) for HIV/Family Planning Services Rakai
评估艾滋病毒/计划生育服务的需求生成(时尚男士) Rakai
  • 批准号:
    8790046
  • 财政年份:
    2014
  • 资助金额:
    $ 182.22万
  • 项目类别:
The Problem With Male Sexual/Repro Health:Qualitative/Quantitative Study, Uganda
男性性/生殖健康问题:定性/定量研究,乌干达
  • 批准号:
    8210227
  • 财政年份:
    2011
  • 资助金额:
    $ 182.22万
  • 项目类别:
The Problem With Male Sexual/Repro Health:Qualitative/Quantitative Study, Uganda
男性性/生殖健康问题:定性/定量研究,乌干达
  • 批准号:
    8331347
  • 财政年份:
    2011
  • 资助金额:
    $ 182.22万
  • 项目类别:
The Problem With Male Sexual/Repro Health:Qualitative/Quantitative Study, Uganda
男性性/生殖健康问题:定性/定量研究,乌干达
  • 批准号:
    8507491
  • 财政年份:
    2011
  • 资助金额:
    $ 182.22万
  • 项目类别:
ARV effects on HIV epidemiology and behaviors in Rakai, Uganda
抗逆转录病毒药物对乌干达拉凯艾滋病毒流行病学和行为的影响
  • 批准号:
    7233967
  • 财政年份:
    2005
  • 资助金额:
    $ 182.22万
  • 项目类别:
ARV effects on HIV epidemiology and behaviors in Rakai, Uganda
抗逆转录病毒药物对乌干达拉凯艾滋病毒流行病学和行为的影响
  • 批准号:
    7494072
  • 财政年份:
    2005
  • 资助金额:
    $ 182.22万
  • 项目类别:
ARV effects on HIV epidemiology & behaviors Rakai Uganda
抗逆转录病毒药物对艾滋病毒流行病学的影响
  • 批准号:
    7417729
  • 财政年份:
    2005
  • 资助金额:
    $ 182.22万
  • 项目类别:
ARV effects on HIV epidemiology & behaviors Rakai Uganda
抗逆转录病毒药物对艾滋病毒流行病学的影响
  • 批准号:
    6947956
  • 财政年份:
    2005
  • 资助金额:
    $ 182.22万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 182.22万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 182.22万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 182.22万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 182.22万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 182.22万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 182.22万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 182.22万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 182.22万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 182.22万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 182.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了